Mitsuharu Ueda

13.8k total citations
396 papers, 7.1k citations indexed

About

Mitsuharu Ueda is a scholar working on Molecular Biology, Physiology and Nephrology. According to data from OpenAlex, Mitsuharu Ueda has authored 396 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 247 papers in Molecular Biology, 77 papers in Physiology and 64 papers in Nephrology. Recurrent topics in Mitsuharu Ueda's work include Amyloidosis: Diagnosis, Treatment, Outcomes (203 papers), Parathyroid Disorders and Treatments (60 papers) and Alzheimer's disease research and treatments (51 papers). Mitsuharu Ueda is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (203 papers), Parathyroid Disorders and Treatments (60 papers) and Alzheimer's disease research and treatments (51 papers). Mitsuharu Ueda collaborates with scholars based in Japan, United States and Italy. Mitsuharu Ueda's co-authors include Yukio Ando, Hirofumi Jono, Taro Yamashita, Yohei Misumi, Konen Obayashi, Masayoshi Tasaki, Soji Ozawa, Satoru Shinriki, Masaki Kitajima and Masaaki Nakamura and has published in prestigious journals such as Science, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Mitsuharu Ueda

363 papers receiving 6.9k citations

Peers

Countries citing papers authored by Mitsuharu Ueda

Since Specialization

Citations

This map shows the geographic impact of Mitsuharu Ueda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsuharu Ueda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsuharu Ueda more than expected).

Fields of papers citing papers by Mitsuharu Ueda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsuharu Ueda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsuharu Ueda. The network helps show where Mitsuharu Ueda may publish in the future.

Co-authorship network of co-authors of Mitsuharu Ueda

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsuharu Ueda. A scholar is included among the top collaborators of Mitsuharu Ueda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsuharu Ueda. Mitsuharu Ueda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Catalytic Photooxygenation Demonstrates Therapeutic Efficacy in Transthyretin Amyloidosis 2025 ·Journal of the American Chemical Society ·(unknown), (unknown), (unknown), Atsushi Iwai, K. Ishihara, (unknown), Harunobu Mitsunuma, Yukiko Hori, Taisuke Tomita, Mineyuki Mizuguchi, (unknown), Mitsuharu Ueda, Yukio Ando, Shigehiro A. Kawashima, Youhei Sohma, Hironori Kaji, Takatsugu Hirokawa, Kunitoshi Yamanaka, Motomu Kanai	0
2	Cardiac Biomarker Change at 1 Year After Tafamidis Treatment and Clinical Outcomes in Patients With Transthyretin Amyloid Cardiomyopathy 2024 ·Journal of the American Heart Association ·(unknown), Seiji Takashio, (unknown), (unknown), Kyoko Hirakawa, Masanobu Ishii, Shinsuke Hanatani, Seitaro Oda, (unknown), Hiroki Usuku, Eiichiro Yamamoto, Toshinori Hirai, Mitsuharu Ueda, Kenichi Tsujita	7
3	Characterization of heterozygous ATTR Tyr114Cys amyloidosis-specific induced pluripotent stem cells 2024 ·Heliyon ·(unknown), Kaori Isono, Yuki Ohya, Nobuaki Shiraki, Masayoshi Tasaki, Yukihiro Inomata, Mitsuharu Ueda, Takumi Era, Shoen Kume, Yukio Ando, Hirofumi Jono	2
4	Effects of tafamidis on the left ventricular and left atrial strain in patients with wild-type transthyretin cardiac amyloidosis 2023 ·European Heart Journal - Cardiovascular Imaging ·(unknown), Hiroaki Kawano, Tsuyoshi Yoshimuta, (unknown), (unknown), (unknown), Daisuke Sato, Masamichi Eguchi, (unknown), Satoshi Ikeda, Mitsuharu Ueda, Koji Maemura	6
5	Prognostic value of right ventricular global longitudinal strain in patients with immunoglobulin light-chain cardiac amyloidosis 2023 ·European Heart Journal Open ·Hiroki Usuku, Eiichiro Yamamoto, Daisuke Sueta, (unknown), Tomohiro Fujisaki, (unknown), Fumi Oike, Koichiro Fujisue, Shinsuke Hanatani, Yuichiro Arima, Seiji Takashio, Yawara Kawano, Seitaro Oda, Hiroaki Kawano, Kenichi Matsushita, Mitsuharu Ueda, Hirotaka Matsui, Masao Matsuoka, Kenichi Tsujita	4
6	A cyclic pyrrole-imidazole polyamide reduces pathogenic RNA in CAG/CTG triplet repeat neurological disease models 2023 ·Journal of Clinical Investigation ·(unknown), Kazuya Matsuo, Yasushi Yabuki, (unknown), Sefan Asamitsu, (unknown), Shingo Usuki, (unknown), Toshikazu Bando, Kimi Araki, Mitsuharu Ueda, Hiroshi Sugiyama, Norifumi Shioda	5
7	World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) 2023 ·Global Heart ·Dulce Brito, (unknown), Diego Pérez de Arenaza, N. Bart, (unknown), (unknown), Isabel Conceição, Thibaud Damy, Sharmila Dorbala, (unknown), Pablo García‐Pavía, Junbo Ge, Julian D. Gillmore, Jacek Grzybowski, Laura Obici, (unknown), Claudio Rapezzi, Mitsuharu Ueda, Fausto J. Pinto	33
8	Myopathic changes caused by protein aggregates in adult‐onset spinal muscular atrophy 2023 ·Neuropathology ·Satoshi Yamashita, (unknown), (unknown), Ichizo Nishino, Mitsuharu Ueda	2
9	Intravenous alteplase before endovascular therapy for acute large vessel occlusion with large ischemic core: subanalysis of a randomized clinical trial 2023 ·Journal of NeuroInterventional Surgery ·Seigo Shindo, Kazutaka Uchida, Shinichi Yoshimura, Nobuyuki Sakai, Hiroshi Yamagami, Ḱazunori Toyoda, Yuji Matsumaru, Yasushi Matsumoto, Kazumi Kimura, Reiichi Ishikura, Manabu Inoue, Fumihiro Sakakibara, Makoto Nakajima, Mitsuharu Ueda, Takeshi Morimoto	4
10	Epidemiological study of the subtype frequency of systemic amyloidosis listed in the Annual of the Pathological Autopsy Cases in Japan 2023 ·Pathology International ·(unknown), Masayoshi Tasaki, Mitsuharu Ueda, Yukio Ando, Hironobu Naiki	3
11	Cytoplasmic p53 aggregates accumulated in p53-mutated cancer correlate with poor prognosis 2022 ·PNAS Nexus ·Naoyuki Iwahashi, (unknown), Yoshihiro Komohara, Yukio Fujiwara, (unknown), (unknown), Kazuko Sakai, Kazuto Nishio, Mitsuharu Ueda, Yoshito Ihara, Kenji Uchimura, Kazuhiko Ino, Kazuchika Nishitsuji	12
12	CT Extracellular Volume Fraction versus Myocardium-to-Lumen Signal Ratio for Cardiac Amyloidosis 2022 ·Radiology ·Masafumi Kidoh, Seitaro Oda, Seiji Takashio, Kyoko Hirakawa, Yawara Kawano, Shinya Shiraishi, Hidetaka Hayashi, Takeshi Nakaura, Yasunori Nagayama, Yoshinori Funama, Mitsuharu Ueda, Kenichi Tsujita, Toshinori Hirai	18
13	gAChR antibodies in children and adolescents with acquired autoimmune dysautonomia in Japan 2021 ·Annals of Clinical and Translational Neurology ·Makoto Yamakawa, (unknown), (unknown), Ichiro Kuki, (unknown), (unknown), Akihiro Mukaino, Osamu Higuchi, Yasuhiro Maeda, Tokunori Ikeda, Koutaro Takamatsu, Nozomu Tawara, Keiichi Nakahara, Hidenori Matsuo, Mitsuharu Ueda, Takao Takahashi, Shunya Nakane	4
14	Anti-Kir4.1 Antibodies in Multiple Sclerosis: Specificity and Pathogenicity 2020 ·International Journal of Molecular Sciences ·(unknown), Osamu Higuchi, Yasuhiro Maeda, Akihiro Mukaino, Mitsuharu Ueda, Hidenori Matsuo, Shunya Nakane	9
15	Clinical, pathological, and proteomic characteristics of newly diagnosed amyloidosis patients: Experience from a single referral center in Japan 2020 ·Neurology and Clinical Neuroscience ·Yukio Ando, Taro Yamashita, Yohei Misumi, Toshiya Nomura, (unknown), (unknown), Yasuteru Inoue, Teruaki Masuda, Mitsuharu Ueda, (unknown), Konen Obayashi, Hirotaka Matsui, Hironobu Naiki	2
16	Patisiran, an RNAi therapeutic for patients with hereditary transthyretin‐mediated amyloidosis: Sub‐analysis in Japanese patients from the APOLLO study 2020 ·Neurology and Clinical Neuroscience ·Taro Yamashita, Mitsuharu Ueda, Haruki Koike, Yoshiki Sekijima, Tsuneaki Yoshinaga, Minori Kodaira, Masahisa Katsuno, Gen Sobue, Xiaoping Zhang, Matthew T. White, Marianne T. Sweetser, Jing Jing Wang, Yukio Ando	4
17	Early diagnosis of ATTR amyloidosis through targeted follow-up of identified carriers ofTTRgene mutations* 2019 ·Amyloid ·Isabel Conceição, Thibaud Damy, Manuel Jesús Romero-Jiménez, Lucía Galán, Shahram Attarian, Marco Luigetti, Menachem Sadeh, Stayko Sarafov, Ivailo Tournev, Mitsuharu Ueda	115
18	Frame Rate Stabilization by Variable Resolution Shape Reconstruction for On-line Free-viewpoint Video Generation 2006 ·Kyushu University Institutional Repository (QIR) (Kyushu University) ·(unknown), (unknown), (unknown), Mitsuharu Ueda, (unknown), (unknown), Daisaku Arita, (unknown), (unknown), Rin‐ichiro Taniguchi, (unknown), (unknown)	1
19	Single-Molecule Analysis of Chemotactic Signaling in Dictyostelium Cells 2001 ·Science ·Mitsuharu Ueda, Yasushi Sako, Toshiki Tanaka, Peter N. Devreotes, Toshio Yanagida	251
20	A new strategy of reperfusion therapy in acute myocardial infarction: Usefulness of a simple and effective thrombus aspiration therapy using a Rescue™ percutaneous thrombectomy system 2001 ·Shigeo Kawano, Ito H, Katsuomi Iwakura, Atsunori Okamura, Yuki Inoue, Akinobu Kato, Katsuaki Asano, (unknown), Kenshi Fujii, Takashi Fujii, Mitsuharu Ueda	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact